{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-24-000075","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.525948+00:00","generated_at":"2026-05-30T10:19:19.726386+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"West Pharma Q3 EPS $1.85 (down from $2.14); raises FY2024 guidance, boosts dividend 5%","bullets":["Q3 net sales $746.9M flat YoY; reported EPS $1.85 vs $2.14; adjusted EPS $1.85 vs $2.16.","FY2024 guidance raised: net sales $2.875B-$2.905B, adjusted EPS $6.55-$6.75 (prior $6.35-$6.65).","Dividend increased 5% to $0.21/share, payable Nov 20, 2024, record Nov 13, 2024.","Proprietary Products net sales $601.4M (-0.2%); Contract-Manufactured $145.5M (+0.4%).","Nine-month free cash flow $191.2M (-32.7%); share repurchases $506.5M in 9M 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-24-000075","json":"https://secwatch.observer/filing/0000105770-24-000075.json","markdown":"https://secwatch.observer/filing/0000105770-24-000075.md","text":"https://secwatch.observer/filing/0000105770-24-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000075/0000105770-24-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577024000075/wst-20241024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:19:19.726386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}